Summitry LLC’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Buy
9,449
+1,244
+15% +$106K 0.02% 121
2026
Q1
$707K Buy
8,205
+211
+3% +$18.9K 0.02% 102
2025
Q4
$698K Buy
7,994
+1,255
+19% +$95.3K 0.03% 89
2025
Q3
$386K Buy
6,739
+920
+16% +$53K 0.02% 128
2025
Q2
$343K Buy
5,819
+1,673
+40% +$108K 0.02% 122
2025
Q1
$303K Buy
4,146
+538
+15% +$44.5K 0.02% 116
2024
Q4
$298K Buy
+3,608
New +$285K 0.01% 107

Other funds holding GMED

Summitry LLC's GMED Position: Q2 2026 in Review

Summitry LLC increased its Globus Medical (GMED) stake by 15% in Q2 2026, buying an estimated $106K and bringing the position to 9,449 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #121.

Summitry LLC first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Summitry LLC held 9,449 shares of Globus Medical worth $747K as of Q2 2026.
  • Summitry LLC bought 1,244 Globus Medical shares in Q2 2026, an estimated $106K.
  • Globus Medical made up 0.02% of Summitry LLC's portfolio in Q2 2026, its #121 holding.
  • Summitry LLC first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.